Gastrointestinal disorders are among the most common health concerns in India, affecting millions of patients every year. Conditions like acid‑related disorders, constipation and diarrhea, and chronic inflammatory bowel diseases (IBD) require effective, safe, and patient‑centric therapeutic options. As healthcare providers and pharma franchise partners look for reliable treatments, Steris Healthcare Pvt. Ltd. emerges as a trusted supplier of high‑quality gastroenterology medicines that meet the evolving needs of clinics, hospitals, and specialty care centers.

The Gastroenterology Range from Steris Healthcare is designed to support a wide spectrum of digestive health issues encountered in clinical practice — from enzyme supplementation to bile acid modulation, controlled‑release therapies, and gut‑specific antimicrobials. This guide explores the portfolio, benefits, clinical use cases, and market relevance of these products in India.

About Steris Healthcare Pvt. Ltd. – Transforming Healthcare Delivery in India

Steris Healthcare Pvt. Ltd. is a rapidly growing pharmaceutical company in India known for its extensive portfolio of high‑quality branded formulations across therapeutic categories, including cardiology, neurology, dermatology, diabetology, and gastroenterology. With over 750+ validated products, Steris Healthcare emphasizes WHO‑GMP and ISO‑certified manufacturing standards, ensuring that each medicine combines efficacy, safety, and clinical reliability for patients and healthcare professionals alike. UniIndia

For B2B partners such as healthcare institutions, distributors, and pharma franchisees, Steris Healthcare represents quality, consistency, and timely supply, enabling stronger patient outcomes and business growth.

Key Gastroenterology Medicines from Steris Healthcare

Below is an overview of important gastroenterology medicines offered by Steris Healthcare, designed to address a broad range of gastrointestinal conditions:

1. REBATERIS 100 – Ribavirin Capsules IP 100 mg

Therapeutic Use:
REBATERIS 100 contains Ribavirin 100 mg, an antiviral agent used in specific viral hepatitis protocols and other gastro‑related viral infections where indicated. While primarily antiviral, it’s part of comprehensive gastro support in chronic liver‑related disease management under specialist supervision.

B2B Value:
Often recommended in combination with other antiviral therapies, REBATERIS 100 supports liver function and disease progression management, reinforcing treatment protocols in gastroenterology practices. Steris Online

2. UDCHOLIC 600 SR – Ursodeoxycholic Acid (600mg)

Therapeutic Use:
UDCHOLIC 600 SR is a sustained‑release formulation of Ursodeoxycholic Acid 600 mg. It plays a key role in managing cholestatic liver diseases, improving bile flow, protecting hepatocytes, and supporting gallstone dissolution where clinically appropriate.

Applications:

• Chronic cholestatic conditions

• Gallstone dissolution (non‑surgical candidates)

• Fatty liver and bile flow enhancement

Clinical Benefits:

• Enhances bile secretion and detoxification

• Supports liver cell protection and regeneration

• Improves digestive comfort in patients with impaired bile acid metabolism sterispharma.in

3. Pancreate 40000 – Pancreatin Minimicrospheres 400mg

Therapeutic Use:
Pancreate 40000 provides pancreatic digestive enzymes — lipase, amylase, and protease — crucial for patients with pancreatic insufficiency, cystic fibrosis, or post‑surgical digestive insufficiency.

Indications:

• Malabsorption syndromes

• Chronic pancreatitis

• Symptoms of incomplete digestion (bloating, steatorrhea)

Benefits in Practice:
This formulation ensures improved nutrient breakdown and absorption, reducing symptoms like bloating and diarrhea, which enhances patient compliance and daily comfort. Steris Pharma

4. BUDEPRESS CR 9 – Budesonide Controlled Release 9 mg

Therapeutic Use:
BUDEPRESS CR 9 contains Budesonide in a Controlled Release formulation, a corticosteroid with targeted anti‑inflammatory action in the gut. It is a key agent in managing Inflammatory Bowel Diseases (IBD) such as Crohn’s disease and ulcerative colitis, where localized control of inflammation is essential.

Clinical Relevance:
The controlled‑release profile allows targeted delivery in the intestines, reducing systemic steroid exposure while effectively controlling disease activity in moderate IBD. Clinicians value its favorable safety profile in long‑term disease control strategies.

5. ADENOSMILE M 400 – Ademetionine 400 mg

Therapeutic Use:
ADENOSMILE M 400 contains Ademetionine, a compound known to support liver function by enhancing methylation processes, stabilizing cell membranes, and aiding hepatocyte repair mechanisms.

Applications:

• Liver support in chronic hepatobiliary disorders

• Adjunctive therapy in alcohol‑related liver dysfunction

• Supportive care in digestive medicine protocols

Clinical Benefits:
Ademetionine supports better overall liver metabolism, improving quality of life in patients with chronic liver burden.

6. RIFAXEMANIA 400 – Rifaximin 400

Therapeutic Use:
RIFAXEMANIA 400 contains Rifaximin 400 mg, a gut‑specific antibiotic widely used in diarrhea management, hepatic encephalopathy support, and small intestinal bacterial overgrowth (SIBO).

Clinical Advantages:

• Broad spectrum antimicrobial activity confined to the GI tract

• Minimal systemic absorption reduces side effects

• Effective in managing traveler’s diarrhea and IBS‑related bowel symptoms when clinically indicated

7. CHOLEDUCE Oral Suspension – Cholestyramine Powder

Therapeutic Use:
CHOLEDUCE is a bile acid sequestrant used to manage cholestatic pruritus, hyperlipidemia-related digestive symptoms, and bile acid‑related diarrhea. By binding bile acids in the gut, it reduces irritation and enhances patient comfort.

8. SLIM BOOST CTSTAT 60 – Cetilistat (60mg)

Therapeutic Use:
SLIM BOOST CTSTAT 60 contains Cetilistat 60 mg, a lipase inhibitor indicated as a supportive therapy in overweight or obesity cases where fat digestion modulation is desired in conjunction with diet and lifestyle measures.

Addressing Common Gastrointestinal Conditions

Acid‑Related Disorders

The gastroenterology range supports management protocols for acid reflex and related ulcerative conditions as part of integrated therapy plans. While specific proton pump inhibitors or H2 blockers might be recommended separately, the Steris portfolio complements these regimens by addressing associated liver and digestive components. Steris Online

Constipation and Diarrhea Management

Products such as RIFAXEMANIA 400 and CHOLEDUCE Oral Suspension are valuable in managing bowel dysfunction, especially where diarrhea is linked to bile acid dysregulation or microbial imbalance. Pancreate also supports normalization of stool consistency in malabsorption cases. Steris Online

Inflammatory Bowel Diseases (IBD)

For healthcare professionals treating IBD, BUDEPRESS CR 9 provides a targeted anti‑inflammatory option with fewer systemic side effects — a key consideration in long‑term IBD care.

Why Steris Healthcare Gastroenterology Range is Considered Among the Best Gastroenterology Medicine in India

1. Diverse Therapeutic Coverage: From digestive enzymes and liver support agents to targeted anti‑inflammatory therapies and gut‑specific antimicrobials. UniIndia

2. Quality Assured: Products comply with global manufacturing standards, ensuring batch‑to‑batch consistency. UniIndia

3. Clinical Relevance: Designed to align with common gastroenterological treatment protocols used in Indian hospitals and clinics.

4. B2B Supply Advantages: Reliable supply chain, franchise support, and consistent availability make Steris a preferred partner for distributors and healthcare facilities.

FAQs – Gastroenterology Medicines by Steris Healthcare

Q1. What conditions do these gastroenterology medicines treat?
These medicines address acid‑related disorders, digestive insufficiency, liver and bile conditions, bacterial imbalance, inflammation (IBD), and bowel dysfunction. Steris Online

Q2. Are these medicines suitable for chronic conditions?
Yes — formulations like BUDEPRESS CR 9 and UDCHOLIC 600 SR are tailored to support long‑term management under medical guidance.

Q3. Can they be distributed through pharma franchises?
Absolutely. Steris Healthcare supports robust B2B partnerships, making these medicines available through franchise and distribution networks.

Q4. Are these products patented or generic?
Steris Healthcare mainly offers branded generic formulations that are cost‑effective and widely prescribed by clinicians.

Q5. Do these medicines require a prescription?
Most products in this range are prescription medicines and should be used under clinician supervision.

Conclusion

The Gastroenterology Range from Steris Healthcare Pvt. Ltd. represents a comprehensive, reliable, and clinically relevant selection of medicines tailored to address a wide range of gastrointestinal conditions in India. From digestive enzyme support and bile flow modulation to gut‑specific antimicrobial action and targeted anti‑inflammatory therapy, these products are designed to meet the evolving needs of gastroenterology practices.